TB Research

Diffuse Alveolar Hemorrhage Caused by Warfarin after Rifampicin Discontinuation

Takashige Kiyota, Seiji Shiota, Ryosuke Hamanaka, Daisuke Tsutsumi, Takeshi Takakura, Eishi Miyazaki

Case Reports in Medicine · 2019-01

Abstract

An 83-year-old man under warfarin therapy presented for assessment of prolonged prothrombin time and cough. High-resolution computed tomography findings of the chest showed diffuse alveolar hemorrhage. His international normalized ratio (INR) was 11.89. He had been treated with rifampicin for a persistent infection, but this had been discontinued about two months before admission. Rifampicin suppresses the anticoagulant activity of warfarin, which can lead to a need for increased doses of warfarin to achieve and maintain a therapeutic INR. More frequent INR monitoring is needed even after discontinuing rifampicin.

MeSH terms

  • Medicine
  • Warfarin
  • Discontinuation
  • Rifampicin
  • Diffuse alveolar hemorrhage
  • Prothrombin time
  • Anticoagulant
  • Anesthesia
  • Surgery
  • Internal medicine